AMVUTTRA
VUTRISIRAN
Listed by Alnylam Pharmaceuticals, Inc.
- Strength
- 25 mg/.5mL
- Form
- Injection
- Route
- Subcutaneous
- Class
- Small Interfering RNA; Transthyretin-directed…
What it contains
- Vutrisiran Sodium 25 mg/.5mL
FDA record
| Dosage form | Injection |
|---|---|
| Route | Subcutaneous |
| Drug class | Small Interfering RNA; Transthyretin-directed RNA Interaction |
| Approval route | NDA — original brand approval |
| NDC code | 71336-1003 |
| FDA application | NDA215515 |
| RxNorm concept | 2604788 |
| Package sizes listed | 1 |
| Marketed since | June 2022 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.